Skip to content
GLP-1 Scorecard
Menu

Head-to-head · WeighScore

Tablet Health vs Ways2Well

Tablet Health
Graded #495

Lower grade

vs+5.299999999999997
Ways2Well
Graded #477

Higher grade

The verdict

Ways2Well takes it — 52.9/100 to 47.6/100.

Ways2Well grades higher on WeighScore, our editorial score across cost value, dose & formulation, clinical oversight, labs & monitoring, fulfillment and contract terms. Ways2Well is a lab-based telehealth and longevity membership founded by Brigham Buhler, offering compounded GLP-1 therapy (semaglutide, with tirzepatide referenced) for weight loss alongside bloodwork,…

We may earn a commission if you start care through some of these links, at no extra cost to you. It never moves the WeighScore, which is the weighted average of the six factors shown for every provider, and what we write about a provider is the same either way. See our disclosure.

Factor by factor

The same six graded dimensions, side by side. See the methodology.

Cost valueEven
45
45
Dose & formulationTablet Health +11
51
40
Clinical oversightWays2Well +28
37
65
Labs & monitoringWays2Well +14
50
64
FulfillmentTablet Health +2
57
55
Contract termsEven
55
55
Tablet Health · left barWays2Well · right bar

The numbers

MetricTablet HealthWays2Well
WeighScore47.6/10052.9/100
GradeCC
Scorecard rank#495#477
SemaglutideNot disclosedNot disclosed
TirzepatideNot disclosedNot disclosed
CoverageCoverage not publishedCoverage not published
Brand-name accessCompounded onlyCompounded only
Oral / sublingualYesInjection only
Tablet Health

Graded #495 · C

Strengths

  • LegitScript Certified
  • Four named compounding pharmacy partners (Pharmacy Hub, Epiq Scripts, Dr. TelX, Emerad), none with FDA warning letters
  • Oral GLP-1 option for both semaglutide and tirzepatide — uncommon in compounded telehealth
  • Mid-tier pricing starting $179–$299/mo across all four product variants
  • No commitment — cancel anytime

Where it loses points

  • States served not published — you must complete the intake quiz to learn eligibility
  • No founder, CEO, medical director, or pharmacist-in-charge named anywhere
  • No BBB profile found
  • Its Queens NYC pharmacy is 'opening soon' — all dispensing currently routes through external partners
  • FDA issued this company a warning letter dated 19 March 2025; the letter is public in FDA's warning-letter database
Ways2Well

Graded #477 · C

Strengths

  • Lab-based, clinician-directed care with bloodwork and biomarker tracking
  • Compounded GLP-1 filled by its named sister pharmacy, ReviveRX
  • Established brand with a named founder (Brigham Buhler) and its own patient app

Where it loses points

  • GLP-1 weight-loss pricing is not published on the live site and is gated behind membership
  • State coverage is limited and not fully listed
  • Requires a membership and clinician protocol rather than a simple standalone GLP-1 plan

Also worth a look

Neither is our top-graded pick — CoreAge Rx leads the scorecard

Across all 499 providers, CoreAge Rx grades highest at 91.8/100 (A−). Top of the scorecard: flat transparent pricing, both molecules, nationwide — no teaser-rate games.

Pricing/verification reflect each provider's public disclosures at last grading; the WeighScore is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.

← Back to the scorecard